A2a Pharmaceuticals, Inc. - Net Worth and Insider Trading
A2a Pharmaceuticals, Inc. Net Worth
The estimated net worth of A2a Pharmaceuticals, Inc. is at least $37 Million dollars as of 2024-05-31. A2a Pharmaceuticals, Inc. is the 10% Owner of Biomea Fusion Inc and owns about 3,500,000 shares of Biomea Fusion Inc (BMEA) stock worth over $37 Million. Details can be seen in A2a Pharmaceuticals, Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that A2a Pharmaceuticals, Inc. has not made any transactions after 2023-06-01 and currently still holds the listed stock(s).
Transaction Summary of A2a Pharmaceuticals, Inc.
A2a Pharmaceuticals, Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, A2a Pharmaceuticals, Inc. owns 1 companies in total, including Biomea Fusion Inc (BMEA) .
Click here to see the complete history of A2a Pharmaceuticals, Inc.’s form 4 insider trades.
Insider Ownership Summary of A2a Pharmaceuticals, Inc.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BMEA | Biomea Fusion Inc | 2023-06-01 | 10 percent owner |
A2a Pharmaceuticals, Inc. Latest Holdings Summary
A2a Pharmaceuticals, Inc. currently owns a total of 1 stock. A2a Pharmaceuticals, Inc. owns 3,500,000 shares of Biomea Fusion Inc (BMEA) as of June 1, 2023, with a value of $37 Million.
Latest Holdings of A2a Pharmaceuticals, Inc.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BMEA | Biomea Fusion Inc | 2023-06-01 | 3,500,000 | 10.46 | 36,610,000 |
Holding Weightings of A2a Pharmaceuticals, Inc.
A2a Pharmaceuticals, Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, A2a Pharmaceuticals, Inc. has made a total of 9 transactions in Biomea Fusion Inc (BMEA) over the past 5 years, including 1 buys and 8 sells. The most-recent trade in Biomea Fusion Inc is the sale of 125,000 shares on June 1, 2023, which brought A2a Pharmaceuticals, Inc. around $4 Million.
Insider Trading History of A2a Pharmaceuticals, Inc.
- 1
A2a Pharmaceuticals, Inc. Trading Performance
GuruFocus tracks the stock performance after each of A2a Pharmaceuticals, Inc.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by A2a Pharmaceuticals, Inc. is -34.24%. GuruFocus also compares A2a Pharmaceuticals, Inc.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by A2a Pharmaceuticals, Inc. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how A2a Pharmaceuticals, Inc.'s insider trading performs compared to the benchmark.
Performance of A2a Pharmaceuticals, Inc.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.92 | | | | | |
| Relative Return to S&P 500(%) | 5.05 | | | | | |
A2a Pharmaceuticals, Inc. Ownership Network
A2a Pharmaceuticals, Inc. Owned Company Details
What does Biomea Fusion Inc do?
Who are the key executives at Biomea Fusion Inc?
A2a Pharmaceuticals, Inc. is the 10 percent owner of Biomea Fusion Inc. Other key executives at Biomea Fusion Inc include Chief Medical Officer Juan Pablo Frias , 10 percent owner Cormorant Asset Management, Lp , and director & 10 percent owner Bihua Chen .
Biomea Fusion Inc (BMEA) Insider Trades Summary
Over the past 18 months, A2a Pharmaceuticals, Inc. made 6 insider transaction in Biomea Fusion Inc (BMEA) with a net sale of 1,000,000. Other recent insider transactions involving Biomea Fusion Inc (BMEA) include a net purchase of 400,000 shares made by Cormorant Global Healthcare Master Fund, Lp ,
In summary, during the past 3 months, insiders sold 0 shares of Biomea Fusion Inc (BMEA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,000,000 shares of Biomea Fusion Inc (BMEA) were sold and 400,000 shares were bought by its insiders, resulting in a net sale of 600,000 shares.
Biomea Fusion Inc (BMEA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biomea Fusion Inc Insider Transactions
A2a Pharmaceuticals, Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for A2a Pharmaceuticals, Inc.. You might contact A2a Pharmaceuticals, Inc. via mailing address: 59 5th Ave, New York Ny 10003.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
